Asthma and COPD according to the pulmonologist
Hisbello da Silva Campos1, Antonio Carlos Moreira Lemos
1Professor Hélio Fraga Referral Center, National School of Public Health, National Ministry of Health, Rio de Janeiro (RJ) Brazil. hisbello@globo.com
Summary
Pulmonologists view chronic obstructive pulmonary disease (COPD) as a significant public health issue, comparable to asthma. They prioritize ease of use over cost when selecting inhaler devices for patients.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Public Health
Background:
- Asthma and COPD significantly impact patients' lives and families.
- Understanding pulmonologists' perspectives on disease management is crucial for optimizing patient care.
Purpose of the Study:
- To assess pulmonologists' perceptions of asthma and COPD's impact on patients.
- To understand current treatment approaches and device preferences for these conditions.
Main Methods:
- A survey was conducted among 227 pulmonologists at major Brazilian respiratory conferences in 2007.
- Data collected focused on disease perception, treatment strategies, and inhaler device selection.
Main Results:
- COPD is considered a public health problem of equal or greater importance than asthma.
- Simplicity of use is prioritized over cost for inhalation devices; Aeroliser and Diskus systems showed slight preference.
- Budesonide-formoterol and tiotropium bromide were frequently cited for asthma and COPD, respectively.
- Treatment choices are heavily influenced by published therapeutic trial data.
Conclusions:
- Pulmonologists' views on asthma and COPD management align with current scientific literature.
- Evidence-based practice strongly influences therapeutic regimen selection in respiratory medicine.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: